Related Experiment Videos
In vitro effects of brodimoprim on human polymorphonuclear leukocyte functions. Preliminary results
E Mini1, A Novelli, M Coronnello
1Dipartimento di Farmacologia, Università degli Studi, Firenze, Italy.
Abstract:
The in vitro effects of brodimoprim and trimethoprim on the functions of human polymorphonuclear (PMN) leukocytes have been studied comparatively evaluating chemotaxis, phagocytosis and production of superoxide anion. No significant effects of both diaminopyrimidines on chemotaxis and phagocytic activity of PMNs have been observed while both brodimoprim and trimethoprim enhanced the oxidative burst. A synergistic activity between the host immune system and the direct antimicrobial action of brodimoprim may occur while using this diaminopyrimidine in vivo.
Insights
Brodimoprim and trimethoprim did not affect human polymorphonuclear (PMN) leukocyte chemotaxis or phagocytosis. However, both drugs enhanced the oxidative burst, suggesting potential in vivo synergy with the immune system.
Area of Science:
- Immunology
- Pharmacology
- Microbiology
Background:
- Diaminopyrimidines like trimethoprim are known for their antimicrobial properties.
- Understanding the interaction between antibiotics and host immune cells is crucial for optimizing therapeutic strategies.
- Polymorphonuclear (PMN) leukocytes play a key role in the innate immune response.
Purpose of the Study:
- To comparatively investigate the in vitro effects of brodimoprim and trimethoprim on human PMN leukocyte functions.
- To evaluate the impact of these diaminopyrimidines on PMN chemotaxis, phagocytosis, and superoxide anion production.
Main Methods:
- In vitro study design.
- Comparative analysis of brodimoprim and trimethoprim.
- Assessment of human PMN leukocyte functions: chemotaxis, phagocytosis, and superoxide anion production (oxidative burst).
Main Results:
- Neither brodimoprim nor trimethoprim significantly affected the chemotaxis or phagocytic activity of human PMNs.
- Both brodimoprim and trimethoprim demonstrated an enhancement of the oxidative burst in PMNs.
- The oxidative burst, a key component of the inflammatory response, was potentiated by both compounds.
Conclusions:
- Brodimoprim and trimethoprim do not impair essential functions of PMN leukocytes, such as migration and engulfment.
- The enhancement of the oxidative burst suggests a potential synergistic interaction between brodimoprim and the host immune system in vivo.
- This observed synergy may contribute to the overall efficacy of brodimoprim as an antimicrobial agent.